Alzheimer's Disease (AD) and other dementias cause a heavy economic and public healthcare burden worldwide. The number of people living with dementia continues to increase mainly due to population aging and growth. Current approved treatments for AD are symptomatic and do not appear to affect disease progression. - Click here if this is your press release! - eTurboNews | Trends | Travel News
/PRNewswire/ Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association.
SINGAPORE, Jan. 13, 2022 /PRNewswire/ Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association (JAMDA)1.
/PRNewswire/ Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association.